GlassScriptPrepare for your visit
Katherine Schultz
Family · Indianapolis, IN · NPI 1972299261
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$363.48
in general payments reported to CMS, 2019-2025 · $42.79 in 2025
The $42.79 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Who reported paying
General payments only, top 4 by amount.
- Silk Road Medical, INC. $300.64
- Terumo Medical Corporation $21.95
- W. L. Gore & Associates, INC. $20.84
- Neurocrine Biosciences, INC. $20.05
Drugs and devices associated with these payments
Enroute Transcarotid Neuroprotection System Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter Enroute Transcarotid Stent Glidewire Azur Cx Detachable Excluder Conformable Aaa Endoprosthesis With Active Control Ingrezza
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Katherine Schultz listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/11482172/katherine-schultz